Potential Drug–Drug Interactions in Prescriptions for Outpatients with Type 2 Diabetes Mellitus at A Private Hospital in Bandar Lampung

Read full text Summarise with VIRAT
Authors: Harum Puspita Ningrum, Elma Viorentina Sembiring, Ageng Hasna Fauziyah
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Diabetes is a chronic metabolic disease characterized by hyperglycemia, with type 2 diabetes mellitus (T2DM) being the most prevalent worldwide. This descriptive quantitative study aimed to identify potential drug–drug interactions (pDDIs) in T2DM outpatients. A total of 100 medical records from the outpatient department in 2024 were selected using accidental sampling. Most patients were female (57%) and aged 46–65 years (72%). Prescriptions commonly contained fewer than seven drugs (87%), with metformin being the most frequently prescribed antidiabetic (30.9%) and sulfonylureas the most common drug class (34.6%). Drug interactions were identified in 76% of prescriptions, predominantly of moderate severity (63.2%) and pharmacokinetic mechanism (50.6%)

Fields of Study & Subjects

Pharmaceutical Practices and Patient Outcomes Pharmacy and Medical Practices Pharmacogenetics and Drug Metabolism

Publication details

Journal / source
Formosa Journal of Science and Technology
Volume
5
Issue
3
Pages
647–662
Publication date
30 March 2026
Language
EN